Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Valves01:16

Heart Valves

4.5K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does prior percutaneous coronary revascularization negatively affect the outcomes of subsequent coronary artery bypass grafting?

The Annals of thoracic surgery·2026
Same author

Outcome After Surgery for Type A Intramural Hematoma.

Journal of cardiovascular development and disease·2026
Same author

Great debate: surgical aortic valve replacement is first choice for aortic stenosis in patients with a life expectancy beyond 5 years.

European heart journal·2026
Same author

Systematic Review and Reconstructed Individual Patient Data of Atherosclerotic Subclavian Artery Aneurysm in the Endovascular Era.

Annals of vascular surgery·2026
Same author

Manufacturing 3D aortic root models for in vitro assessment of calcific aortic valve stenosis.

Annals of biomedical engineering·2026
Same author

Interaction between alveolar diffusing capacity and B-lines in heart failure with preserved ejection fraction - A non-invasive exercise study.

International journal of cardiology·2026

Related Experiment Video

Updated: Jun 23, 2025

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.4K

[Total artificial heart: past, present, and future].

Gina Mazzeo1, Alessandra Francica1, Daniela Piani2

  • 1Divisione di Cardiochirurgia, Azienda Ospedaliera Universitaria Integrata, Verona.

Giornale Italiano Di Cardiologia (2006)
|June 25, 2024
PubMed
Summary
This summary is machine-generated.

Advanced heart failure affects many, with high mortality despite treatments. A total artificial heart offers a vital option for end-stage patients ineligible for heart transplants or left ventricular assist devices.

More Related Videos

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.3K
Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

24.6K

Related Experiment Videos

Last Updated: Jun 23, 2025

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.4K
Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.3K
Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

24.6K

Area of Science:

  • Cardiology
  • Medical Technology
  • Surgical Innovation

Background:

  • Advanced heart failure affects 1-2% of adults, with significant 1-year and 5-year mortality rates.
  • Heart transplantation is limited by donor-recipient mismatch, necessitating alternative treatments.
  • Mechanical circulatory support, including extracorporeal membrane oxygenation and left ventricular assist devices, plays a crucial role.

Purpose of the Study:

  • To discuss the role of total artificial hearts in managing end-stage heart failure.
  • To highlight the limitations of current treatments and the need for advanced solutions.
  • To explore the total artificial heart as a therapeutic option for specific patient populations.

Main Methods:

  • Review of current literature on heart failure management and mechanical circulatory support.
  • Analysis of patient cases where left ventricular assist devices are not suitable.
  • Discussion of the clinical implications and potential of total artificial hearts.

Main Results:

  • Mechanical circulatory support systems are vital for critically ill heart failure patients.
  • Biventricular dysfunction can preclude the use of left ventricular assist devices.
  • Total artificial hearts present a viable therapeutic option for select end-stage heart failure patients.

Conclusions:

  • Total artificial hearts offer a life-saving alternative for patients with end-stage heart failure and biventricular dysfunction.
  • This technology addresses critical gaps in heart failure treatment, particularly when transplantation or LVADs are not feasible.
  • Further research and clinical application of total artificial hearts are warranted.